$10.34
-0.46-4.26%
al cierre: Nov 20, 4:00 PM EST
$10.20
-0.14-1.35%
After hour: 6:00 PM EST
El interés corto en 4D Molecular Therapeutics Inc (NASDAQ:FDMT) ha aumentado durante el último período de informe, aumentando en aumento desde 4.22M hasta 4.27M. Esto representa el 7.72% de las acciones disponibles públicamente de la empresa.
Basado en el volumen promedio reciente de 980.07K acciones negociadas por día, tomaría 4.36 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
FDMT | 4D Molecular Therapeutics, Inc | 10/31/2025 | 11/11/2025 | 7.72% | 55,305,878 | 4,271,739 | 980,066 | 4.36 | |
FDMT | 4D Molecular Therapeutics, Inc | 10/15/2025 | 10/24/2025 | 9.40% | 44,873,270 | 4,219,162 | 735,599 | 5.74 | |
FDMT | 4D Molecular Therapeutics, Inc | 09/30/2025 | 10/09/2025 | 10.00% | 44,873,270 | 4,488,864 | 779,153 | 5.76 | |
FDMT | 4D Molecular Therapeutics, Inc | 09/15/2025 | 09/24/2025 | 10.46% | 44,873,270 | 4,691,697 | 559,252 | 8.39 | |
FDMT | 4D Molecular Therapeutics, Inc | 08/29/2025 | 09/10/2025 | 9.57% | 44,873,270 | 4,295,623 | 655,621 | 6.55 | |
FDMT | 4D Molecular Therapeutics, Inc | 08/15/2025 | 08/26/2025 | 9.23% | 44,873,270 | 4,142,441 | 4,040,836 | 1.03 | |
FDMT | 4D Molecular Therapeutics, Inc | 07/31/2025 | 08/11/2025 | 8.32% | 44,495,445 | 3,703,248 | 459,039 | 8.07 | |
FDMT | 4D Molecular Therapeutics, Inc | 07/15/2025 | 07/24/2025 | 8.13% | 44,495,445 | 3,619,133 | 332,098 | 10.9 | |
FDMT | 4D Molecular Therapeutics, Inc | 06/30/2025 | 07/10/2025 | 8.73% | 44,495,445 | 3,885,430 | 460,765 | 8.43 | |
FDMT | 4D Molecular Therapeutics, Inc | 06/13/2025 | 06/25/2025 | 9.38% | 44,495,445 | 4,171,819 | 530,228 | 7.87 | |
FDMT | 4D Molecular Therapeutics, Inc | 05/30/2025 | 06/10/2025 | 9.78% | 44,495,445 | 4,352,742 | 396,858 | 10.97 | |
FDMT | 4D Molecular Therapeutics, Inc | 05/15/2025 | 05/27/2025 | 10.49% | 44,495,445 | 4,668,859 | 517,013 | 9.03 | |
FDMT | 4D Molecular Therapeutics, Inc | 04/30/2025 | 05/09/2025 | 11.33% | 44,495,445 | 5,039,643 | 424,039 | 11.88 | |
FDMT | 4D Molecular Therapeutics, Inc | 04/15/2025 | 04/25/2025 | 11.71% | 44,422,430 | 5,200,870 | 995,479 | 5.22 | |
FDMT | 4D Molecular Therapeutics, Inc | 03/31/2025 | 04/09/2025 | 11.38% | 44,422,430 | 5,057,335 | 706,355 | 7.16 | |
FDMT | 4D Molecular Therapeutics, Inc | 03/14/2025 | 03/25/2025 | 11.32% | 44,422,430 | 5,028,368 | 721,909 | 6.97 | |
FDMT | 4D Molecular Therapeutics, Inc | 02/28/2025 | 03/11/2025 | 11.80% | 44,422,430 | 5,241,024 | 601,496 | 8.71 | |
FDMT | 4D Molecular Therapeutics, Inc | 02/14/2025 | 02/26/2025 | 13.88% | 44,422,430 | 6,167,568 | 1,323,298 | 4.66 | |
FDMT | 4D Molecular Therapeutics, Inc | 01/31/2025 | 02/11/2025 | 16.65% | 44,422,430 | 7,397,347 | 639,933 | 11.56 | |
FDMT | 4D Molecular Therapeutics, Inc | 01/15/2025 | 01/27/2025 | 17.27% | 44,422,430 | 7,672,441 | 776,503 | 9.88 | |
FDMT | 4D Molecular Therapeutics, Inc | 12/31/2024 | 01/10/2025 | 17.98% | 44,422,430 | 7,986,854 | 1,351,357 | 5.91 | |
FDMT | 4D Molecular Therapeutics, Inc | 12/13/2024 | 12/24/2024 | 20.07% | 44,422,430 | 8,917,026 | 588,395 | 15.15 | |
FDMT | 4D Molecular Therapeutics, Inc | 11/29/2024 | 12/10/2024 | 19.19% | 44,422,430 | 8,522,668 | 999,899 | 8.52 | |
FDMT | 4D Molecular Therapeutics, Inc | 11/15/2024 | 11/26/2024 | 17.62% | 44,422,430 | 7,827,058 | 821,166 | 9.53 | |
FDMT | 4D Molecular Therapeutics, Inc | 10/31/2024 | 11/11/2024 | 16.31% | 50,164,311 | 8,182,326 | 741,545 | 11.03 | |
FDMT | 4D Molecular Therapeutics, Inc | 10/15/2024 | 10/24/2024 | 18.92% | 50,164,311 | 9,490,542 | 913,610 | 10.39 | |
FDMT | 4D Molecular Therapeutics, Inc | 09/30/2024 | 10/09/2024 | 21.78% | 50,164,311 | 10,925,855 | 1,429,600 | 7.64 | |
FDMT | 4D Molecular Therapeutics, Inc | 09/13/2024 | 09/24/2024 | 18.97% | 50,164,311 | 9,517,746 | 410,862 | 23.17 | |
FDMT | 4D Molecular Therapeutics, Inc | 08/30/2024 | 09/11/2024 | 19.68% | 50,164,311 | 9,873,630 | 449,647 | 21.96 | |
FDMT | 4D Molecular Therapeutics, Inc | 08/15/2024 | 08/26/2024 | 19.84% | 50,164,311 | 9,953,253 | 580,789 | 17.14 | |
FDMT | 4D Molecular Therapeutics, Inc | 07/31/2024 | 08/09/2024 | 19.00% | 50,164,311 | 9,530,709 | 2,033,191 | 4.69 | |
FDMT | 4D Molecular Therapeutics, Inc | 07/15/2024 | 07/24/2024 | 20.73% | 49,898,133 | 10,344,746 | 547,889 | 18.88 | |
FDMT | 4D Molecular Therapeutics, Inc | 06/28/2024 | 07/10/2024 | 19.82% | 49,898,133 | 9,891,860 | 909,558 | 10.88 | |
FDMT | 4D Molecular Therapeutics, Inc | 06/14/2024 | 06/26/2024 | 19.44% | 49,898,133 | 9,701,494 | 586,920 | 16.53 | |
FDMT | 4D Molecular Therapeutics, Inc | 05/31/2024 | 06/11/2024 | 19.19% | 49,898,133 | 9,575,719 | 480,501 | 19.93 | |
FDMT | 4D Molecular Therapeutics, Inc | 05/15/2024 | 05/24/2024 | 19.33% | 49,898,133 | 9,646,011 | 421,320 | 22.89 | |
FDMT | 4D Molecular Therapeutics, Inc | 04/30/2024 | 05/09/2024 | 19.28% | 49,898,133 | 9,622,548 | 433,843 | 22.18 | |
FDMT | 4D Molecular Therapeutics, Inc | 04/15/2024 | 04/24/2024 | 19.93% | 49,352,193 | 9,834,818 | 812,049 | 12.11 | |
FDMT | 4D Molecular Therapeutics, Inc | 03/28/2024 | 04/09/2024 | 18.88% | 49,352,193 | 9,317,980 | 673,496 | 13.84 | |
FDMT | 4D Molecular Therapeutics, Inc | 03/15/2024 | 03/26/2024 | 21.34% | 39,825,055 | 8,500,234 | 857,701 | 9.91 | |
FDMT | 4D Molecular Therapeutics, Inc | 02/29/2024 | 03/11/2024 | 20.95% | 39,825,055 | 8,344,171 | 678,962 | 12.29 | |
FDMT | 4D Molecular Therapeutics, Inc | 02/15/2024 | 02/27/2024 | 17.93% | 39,385,395 | 7,061,371 | 3,558,792 | 1.98 | |
FDMT | 4D Molecular Therapeutics, Inc | 01/31/2024 | 02/09/2024 | 9.74% | 39,386,550 | 3,835,135 | 481,536 | 7.96 | |
FDMT | 4D Molecular Therapeutics, Inc | 01/12/2024 | 01/24/2024 | 8.78% | 32,800,535 | 2,880,449 | 349,325 | 8.25 | |
FDMT | 4D Molecular Therapeutics, Inc | 12/29/2023 | 01/10/2024 | 9.82% | 32,800,535 | 3,220,145 | 490,653 | 6.56 | |
FDMT | 4D Molecular Therapeutics, Inc | 12/15/2023 | 12/27/2023 | 12.00% | 32,800,535 | 3,934,660 | 391,511 | 10.05 | |
FDMT | 4D Molecular Therapeutics, Inc | 11/30/2023 | 12/11/2023 | 10.97% | 32,800,535 | 3,597,841 | 217,931 | 16.51 | |
FDMT | 4D Molecular Therapeutics, Inc | 11/15/2023 | 11/27/2023 | 11.49% | 32,800,535 | 3,767,763 | 350,884 | 10.74 |
En busca de los valores más cortos?